Ultrastructural changes in minimal lesion nephrotic syndrome before and during cyclophosphamide therapy.
D000293:Adolescent; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000648:ultrastructure*; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000473:pathology
D003520:Cyclophosphamide